Field trial of cyfluthrin as an effective and safe insecticide for control of malaria vectors in triple insecticide resistant areas.

Cyfluthrin (Solfac**) 10 wp, a synthetic pyrethroid was evaluated for its efficacy in malaria control through primary health centre approach, and for its acceptance by the community and effect on human health, and non target organisms, in predominantly tribal areas of Maharashtra and Gujarat from 1988 to 1990. Two dosage schedules; 2 rounds of indoor residual sparying a year, at 25 mg/sq. m2 in Maharashtra, and 3 rounds a year at 15 mg/sq. m2, in Gujarat were followed. There was significant reduction in per man hour densities of An. culicifacies the principal malaria vector, and collaterally of C. quinquefasciatus also. Significant reductions in slide positivity rates and slide falciparum rates were observed in both the areas as compared to the controls. The community acceptance of Cyfluthrin in terms of room coverage was 96% in Gujarat, and 89% in Maharashtra, as against average 68.5% and 55% in case of DDT and Malathion respectively. There were no reported ill-effects on humans or non-target organisms.